Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69 A, Issue 3, 2014, Pages 260-269

  Baron, Stephanie ^a,b   Bedarida, Tatiana ^a   Cottart, Charles Henry ^a,c   Vibert, Francoise ^a   Vessieres, Emilie ^d   Ayer, Audrey ^d   Henrion, Daniel ^d   Hommeril, Baptiste ^b   Paul, Jean Louis ^b,e   Renault, Gilles ^f   Saubamea, Bruno ^a   Beaudeux, Jean Louis ^a,g   Procaccio, Vincent ^d   Nivet Antoine, Valerie ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d INSERM   (France)

^e EA 4529   (France)

^f INSTITUT COCHIN   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Aging; Insulin resistance; Renutrition; Resveratrol; Vascular disease

Indexed keywords

ANTIOXIDANT; CCL5 PROTEIN, MOUSE; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; LEPTIN; PHENOL DERIVATIVE; RANTES; RESISTIN; RESVERATROL; RETN PROTEIN, MOUSE; RIBONUCLEOTIDE REDUCTASE; SERUM ALBUMIN; STILBENE DERIVATIVE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL; AORTA; ARTICLE; BLOOD; BLOOD VESSEL CAPACITANCE; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INBRED MOUSE STRAIN; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PHYSIOLOGY; PROTEIN INTAKE; RENUTRITION.; VASCULAR DISEASE; VASODILATATION;

AGING; INSULIN RESISTANCE; RENUTRITION.; RESVERATROL; VASCULAR DISEASE;

AGING; ANIMALS; ANTIOXIDANTS; AORTA; BLOOD GLUCOSE; CHEMOKINE CCL5; CHEMOKINE CXCL1; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; INSULIN RESISTANCE; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PHENOLS; RESISTIN; RIBONUCLEOTIDE REDUCTASES; SERUM ALBUMIN; STILBENES; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CAPACITANCE; VASCULAR DISEASES; VASODILATION;

EID: 84896803058     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt081     Document Type: Article

References (57)

1. Verhagen SN, Wassink AM, Van Der Graaf Y, Gorter PM, Visseren FL; SMART Study Group. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovasc Diabetol. 2011;10:100.
2. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944-948.
3. Hebert-Schuster M, Fabre EE, Nivet-Antoine V. Catalase polymorphisms and metabolic diseases. Curr Opin Clin Nutr Metab Care. 2012;15:397-402.
4. Abel ED, O'Shea KM, Ramasamy R. Insulin resistance: metabolic mechanisms and consequences in the heart. Arterioscler thromb vasc Biol. 2012;32:2068-2076.
5. Hasegawa Y, Saito T, Ogihara T, et al. Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans. Circulation. 2012;125:1122-1133.
6. Hebert-Schuster M, Cottart CH, Laguillier-Morizot C, et al. Catalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame? free Radic Biol Med. 2011;51:1583-1588.
7. Fabre EE, Raynaud-Simon A, Golmard JL, et al. Gene polymorphisms of oxidative stress enzymes: prediction of elderly renutrition. Am J Clin Nutr. 2008;87:1504-1512.
8. Ungvari Z, Kaley G, De Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010;65:1028-1041.
9. Collins AR, Lyon CJ, Xia X, et al. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res. 2009;104:e42-e54.
10. Nivet-Antoine V, Labat C, El Shamieh S, et al. Relationship between catalase haplotype and arterial aging. Atherosclerosis. 2013;227:100-105.
11. HAS (Haute Autorité de Santé). Clinical Practice Guidelines. Nutritional Support Strategy for Protein-Energy Malnutrition in the Elderly. Saint-Denis, France: HAS; 2007.
12. Foo SY, Heller ER, Wykrzykowska J, et al. Vascular effects of a low-carbohydrate high-protein diet. Proc Natl Acad Sci U S A. 2009;106:15418-15423.
13. Hassan-Khabbar S, Cottart CH, Wendum D, et al. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery. Liver transpl. 2008;14:451-459.
14. Hassan-Khabbar S, Vamy M, Cottart CH, et al. Protective effect of post-ischemic treatment with trans-resveratrol on cytokine production and neutrophil recruitment by rat liver. Biochimie. 2010;92:405-410.
15. Nivet-Antoine V, Cottart CH, Lemaréchal H, et al. trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemiareperfusion. Biochimie. 2010;92:1766-1771.
16. Brasnyó P, Molnár GA, Mohás M, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106:383-389.
17. Cottart CH, Nivet-Antoine V, Beaudeux JL. A review of recent data on the metabolism, biological effects and toxicity of resveratrol in humans. Mol Nutr food Res. 2013. doi:10.1002/mnfr.201200589. In press.
18. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14:612-622.
19. Crandall JP, Oram V, Trandafirescu G, et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci. 2012;67:1307-1312.
20. Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458:1056-1060.
21. Chung JH, Manganiello V, Dyck JR. Resveratrol as a calorie restriction mimetic: therapeutic implications. trends Cell Biol. 2012;22:546-554.
22. Baur JA, Ungvari Z, Minor RK, Le Couteur DG, De Cabo R. Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov. 2012;11:443-461.
23. Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012;15:675-690.
24. Feige JN, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008;8:347-358.
25. Do GM, Kwon EY, Kim HJ, et al. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun. 2008;374:55-59.
26. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506.
27. Wang C, Wheeler CT, Alberico T, et al. The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age (Dordr). 2013;35:69-81.
28. Park SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148:421-433.
29. Nijmeh J, Moldobaeva A, Wagner EM. Role of ROS in ischemiainduced lung angiogenesis. Am J Physiol Lung Cell Mol Physiol. 2010;299:L535-L541.
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods. 2001;25:402-408.
32. Loufrani L, Dubroca C, You D, et al. Absence of dystrophin in mice reduces NO-dependent vascular function and vascular density: total recovery after a treatment with the aminoglycoside gentamicin. Arterioscler thromb vasc Biol. 2004;24:671-676.
33. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
34. Bouillanne O, Morineau G, Dupont C, et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82:777-783.
35. Nivet-Antoine V, Golmard JL, Coussieu C, Piette F, Cynober L, Bouillanne O. Leptin is better than any other biological parameter for monitoring the efficacy of renutrition in hospitalized malnourished elderly patients. Clin Endocrinol (Oxf). 2011;75:315-320.
36. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP; Cardiovascular Study Research Group. Weight change in old age and its association with mortality. J Am Geriatr Soc. 2001;49:1309-1318.
37. Walrand S, Chambon-Savanovitch C, Felgines C, et al. Aging: a barrier to renutrition? Nutritional and immunologic evidence in rats. Am J Clin Nutr. 2000;72:816-824.
38. Suvorava T, Lauer N, Kumpf S, Jacob R, Meyer W, Kojda G. Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation. 2005;112:2487-2495.
39. Suvorava T, Kojda G. Reactive oxygen species as cardiovascular mediators: lessons from endothelial-specific protein overexpression mouse models. Biochim Biophys Acta. 2009;1787:802-810.
40. Bouillanne O, Golmard JL, Coussieu C, et al. Leptin a new biological marker for evaluating malnutrition in elderly patients. Eur J Clin Nutr. 2007;61:647-654.
41. Di Francesco V, Fantin F, Omizzolo F, et al. The anorexia of aging. Dig Dis. 2007;25:129-137.
42. Atherton HJ, Gulston MK, Bailey NJ, et al. Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse. Mol Syst Biol. 2009;5:259.
43. Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, Grant R. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One. 2011;6:e19194.
44. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7:e42357.
45. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes. 2003;52:1-8.
46. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab. 2002;282:E834-E842.
47. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
48. Tripathy D, Mohanty P, Dhindsa S, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 2003;52:2882-2887.
49. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000;49:1231-1238.
50. De Silva HV, Más-Oliva J, Taylor JM, Mahley RW. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J Lipid Res. 1994;35:1297-1310.
51. Le Boeuf RC, Tsao WW, Kiirk E, Childs MT. Cholesterol feeding induces cholesterol-rich VLDL in atherosclerosis-susceptible mice regardless of dietary fat content. Nutr Res. 1993;13:549-561.
52. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8:157-168.
53. Barger JL, Kayo T, Vann JM, et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One. 2008;3:e2264.
54. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109-1122.
55. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. fASEB J. 2008;22:659-661.
56. Zhou Z, Subramanian P, Sevilmis G, et al. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab. 2011;13:592-600.
57. Abraham J, Johnson RW. Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice. Rejuvenation Res. 2009;12:445-453.